白丝美女被狂躁免费视频网站,500av导航大全精品,yw.193.cnc爆乳尤物未满,97se亚洲综合色区,аⅴ天堂中文在线网官网

Systems and methods for producing Actinium-225

專利號(hào)
US10867716B1
公開日期
2020-12-15
申請(qǐng)人
King Abdulaziz University（SA Jeddah）
發(fā)明人
Fouad Abolaban; Essam M. Banoqitah; Eslam M. Taha; Abdulsalam M. Alhawsawi; Fathi Djouider; Andrew Nisbet
IPC分類
G21G1/06; A61N5/10; G21G1/00
技術(shù)領(lǐng)域
neutron,proton,actinium,mev,racl2,neutrons,protons,energy,target,doi
地域： Jeddah

摘要

An Actinium-225 generator is provided. The generator includes a neutron source; a neutron target arranged to receive neutrons emitted from the neutron source, wherein the neutron target comprises nickel; and a proton target arranged to receive protons emitted from the neutron target, wherein the proton target comprises radium-226. Methods for producing Actinium-225 are also provided.

說明書

  • [4] B. J. Davison, M. E. Gleave, S. L. Goldenberg, L. F. Degner, D. Hoffart, and J. Berkowitz, “Assessing information and decision preferences of men with prostate cancer and their partners,” Cancer Nurs., vol. 25, no. 1, pp. 42-49, January 2002.
  • [5] M. S. Hofman et al., “[177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study,” Lancet Oncol., vol. 19, no. 6, pp. 825-833, June 2018, doi: 10.1016/S1470-2045(18)30198-0.
  • [6] Y. Li, Z. Tian, S. Rizvi, N. Bander, B. Allen, and S. Wales, “In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen,” Prostate Cancer Prostatic Dis., vol. 5, pp. 36-46, 2002, doi: 10.1038/sj/pcan/4500543.
  • [7] E. Azorín-Vega, E. Rojas-Calderon, G. Ferro-Flores, L. Aranda-Lara, N. Jimenez-Mancilla, and M. A. Nava-Cabrera, “Assessment of the radiation absorbed dose produced by 177 LuiPSMA, 225 Ac-iPSMA and 223 RaCl 2 to prostate cancer cell nuclei in a bone microenvironment model,” Appl. Radiat. Isot., vol. 146, no. January, pp. 66-71, 2019, doi: 10.1016/j.apradiso.2019.01.020.
  • [8] J. Ahn, S. Park, B. Zuniga, A. Bera, C. S. Song, and B. Chatterjee, “Vitamin D in Prostate Cancer,” in Vitamins and Hormones, vol. 100, Academic Press Inc., 2016, pp. 321-355.
  • [9] D. L. Ludwig et al., “Preclinical Development of an Actinium-225-Labeled Antibody Radio-Conjugate Directed Against CD45 for Targeted Conditioning and Radioimmunotherapy,” Biol. Blood Marrow Transplant., vol. 26, no. 3, pp. S160-S161, 2020, doi: 10.1016/j.bbmt.2019.12.714.

    • 權(quán)利要求

    1
    微信群二維碼
    意見反饋